LANTERN PHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.5 USD | +0.73% |
|
+3.00% | +28.50% |
| Apr. 24 | Transcript : Lantern Pharma Inc. - Special Call | |
| Apr. 22 | Lantern Gets Regulatory Approval in Japan, Taiwan for Non-Small Cell Lung Cancer Trial Expansion | MT |
Chart calendar Lantern Pharma Inc.
080.giXie6RAD6XAlsm-uv3MQEl8k0ERlgCSrKljWHP2pQw.8AiJSuwBYOaW77jI38i7JzoRviZX2Wnm9sovKEGwkX3oYotMky9N_bXQpg~1e78bbe3f9ab8ba0df6f917641abab9c
Upcoming events on Lantern Pharma Inc.
Past events on Lantern Pharma Inc.
| 2024-03-19 | Rare Disease Summit |
| 2024-03-18 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-18 04:02 pm | Q4 2023 Earnings Release |
| 2024-03-07 02:00 pm | H.C. Wainwright Artificial Intelligence Based Drug Discovery & Development Virtual Conference - Fire |
| 2023-12-05 01:30 pm | CNS Drug Delivery Summit |
| 2023-12-01 01:30 am | Bengaluru Tech Summit |
| 2023-11-17 01:55 pm | Society for Neuro Oncology Meeting |
| 2023-11-08 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-08 04:01 pm | Q3 2023 Earnings Release |
| 2023-10-19 01:30 pm | ThinkEquity Conference |
| 2023-09-06 07:00 pm | Society of Hematologic Oncology Meeting - Poster Number: ABCL-180 |
| 2023-08-24 03:45 am | Drug Conjugates for Directed Therapy International Conference |
| 2023-08-10 08:30 pm | American Society of Clinical Oncology CNS Cancer Conference |
| 2023-08-09 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-09 04:01 pm | Q2 2023 Earnings Release |
| 2023-07-22 | Cancer Molecular Therapeutics Research Association Conference |
| 2023-07-16 | Biotech CEO Summit |
| 2023-06-16 11:00 am | Annual General Meeting |
| 2023-05-18 09:00 am | Lytham Partners Spring Investor Conference |
| 2023-05-09 | EF Hutton Global Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -12,6 -13,3 5.38% | -13,2 -14,5 8.72% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -5,91 -5,84 -1.13% | -12,6 -13,6 7.73% | -14,4 -16,1 10.52% | -17,9 -17,8 -0.49% | -24,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,91 -5,81 -1.66% | -12,4 -13,2 6.24% | -14,3 -16,3 12.42% | -16,0 -16,1 1% | -23,3 |
|
Net income Million USD | Released Forecast Spread | -5,91 -5,81 -1.66% | -12,4 -13,2 6.24% | -14,3 -16,2 12.01% | -16,0 -16,4 2.96% | -23,0 |
|
EPS USD | Released Forecast Spread | -1,37 -1,35 -1.48% | -1,13 -1,21 6.22% | -1,31 -1,48 11.49% | -1,47 -1,51 2.43% | -2,03 |
| Announcement Date | 10/03/21 | 10/03/22 | 20/03/23 | 18/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -3,51 -4,20 16.45% | -4,06 -3,60 -12.9% | -1,84 -4,40 58.15% | -3,49 -4,70 25.67% | -3,95 -5,00 21.01% | -4,79 -5,30 9.54% | |||||||
|
EBIT Million USD | Released Forecast Spread | -3,51 -4,59 23.54% | -4,07 -3,60 -12.96% | -4,39 -5,65 22.17% | -2,15 -5,30 59.53% | -3,83 -5,19 26.29% | -4,29 -5,30 19.13% | -5,19 -4,91 -5.69% | -3,52 -5,15 31.51% | -4,88 -4,63 -5.24% | -5,40 | -5,90 | -6,50 | -7,10 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,54 -4,37 18.92% | -4,12 -3,20 -28.81% | -4,49 -5,63 20.19% | -2,26 -5,24 56.81% | -3,38 -5,14 34.16% | -3,87 -5,20 25.62% | -4,75 -4,74 -0.19% | -3,16 -4,94 35.94% | -4,19 -4,33 3.43% | -4,70 | -5,30 | -5,90 | -6,60 |
|
Net income Million USD | Released Forecast Spread | -3,54 -4,37 18.92% | -4,12 -3,20 -28.81% | -4,49 -5,63 20.19% | -2,26 -5,24 56.81% | -3,38 -5,14 34.16% | -3,87 -5,20 25.62% | -4,75 -4,74 -0.19% | -3,16 -4,94 35.94% | -4,19 -4,33 3.43% | -4,70 | -5,30 | -5,90 | -6,60 |
|
EPS USD | Released Forecast Spread | -0,31 -0,39 20.51% | -0,38 -0,29 -31.03% | -0,41 -0,52 21.15% | -0,21 -0,48 56.25% | -0,31 -0,47 34.04% | -0,36 -0,48 25% | -0,44 -0,43 -1.54% | -0,29 -0,46 36.26% | -0,38 -0,40 5% | -0,43 | -0,48 | -0,54 | -0,60 |
| Announcement Date | 10/03/22 | 03/05/22 | 08/08/22 | 07/11/22 | 20/03/23 | 09/05/23 | 09/08/23 | 08/11/23 | 18/03/24 | - | - | - | - |
| Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Lantern Pharma Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LTRN Stock
- Calendar Lantern Pharma Inc.
